Eli Lilly & Co. (NYSE:LLY)

Top Presentations to Look for at ASCO

It almost the end of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2017 annual meeting ...
Read Full Story »

Big Pharma Has Big Catalysts Coming for the Rest of 2017

The big pharmaceutical stocks are one area that has done somewhat better this year. One major reason for that is the shrill rhetoric from politicians has quieted as the election ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

What to Expect From Eli Lilly at ASCO

In the coming weeks, biotech and pharma companies will descend on Chicago for one of the biggest conferences in 2017. The 2017 annual meeting of the American Society of Clinical ...
Read Full Story »

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse analyst Vamil Divan has released an outlook on the pharmaceutical sector. While the weighting for the sector is Market Weight, there are some positives in the call. The ...
Read Full Story »

Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves

It is no secret that pharma and biotech shares have had to deal with at least some headwinds over the past year. It turns out that drug pricing concerns and ...
Read Full Story »

Short Interest in Major Pharma Shrinks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

One segment in the markets that has been dogged with issues for almost two years is the big pharmaceuticals, as numerous factors have kept the lid on share prices and, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amex, Cisco, Eli Lilly, First Solar, McDonald’s, Microsoft, US Steel and More

Stocks were indicated higher on Thursday morning after the European Central Bank kept rates steady and after a U.S. durable goods report for March showed a smaller gain than expected. ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Big Pharma and Big Biotech sometimes live and die by actions out of the U.S. Food and Drug Administration (FDA). For Eli Lilly and Co. (NYSE: LLY) and Incyte Corp. (NASDAQ: ...
Read Full Story »

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

One thing that crept on the radar screen last week is that after eight years of a bull market, five of which are of the secular variety, after the S&P 500 ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Analysts Keep Stacking Up Higher Targets and Expectations for Eli Lilly

Eli Lilly and Co. (NYSE: LLY) is one of the better pharmaceutical stocks, as far as performers in 2017 top picks at JPMorgan. Its shares were last seen up 17% ...
Read Full Story »

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »